These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

204 related items for PubMed ID: 36454699

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Tolvaptan, a selective oral vasopressin V2 receptor antagonist, ameliorates podocyte injury in puromycin aminonucleoside nephrotic rats.
    Okada T, Sakaguchi T, Hatamura I, Saji F, Negi S, Otani H, Muragaki Y, Kawachi H, Shigematsu T.
    Clin Exp Nephrol; 2009 Oct; 13(5):438-446. PubMed ID: 19452240
    [Abstract] [Full Text] [Related]

  • 4. Retinoids as a potential treatment for experimental puromycin-induced nephrosis.
    Moreno-Manzano V, Mampaso F, Sepúlveda-Muñoz JC, Alique M, Chen S, Ziyadeh FN, Iglesias-de la Cruz MC, Rodríguez J, Nieto E, Orellana JM, Reyes P, Arribas I, Xu Q, Kitamura M, Lucio Cazana FJ.
    Br J Pharmacol; 2003 Jun; 139(4):823-31. PubMed ID: 12813006
    [Abstract] [Full Text] [Related]

  • 5. Sialic acid supplementation ameliorates puromycin aminonucleoside nephrosis in rats.
    Pawluczyk IZ, Najafabadi MG, Brown JR, Bevington A, Topham PS.
    Lab Invest; 2015 Sep; 95(9):1019-28. PubMed ID: 26121320
    [Abstract] [Full Text] [Related]

  • 6. Renoprotection by continuous erythropoietin receptor activator in puromycin aminonucleoside-induced nephrotic syndrome.
    Aizawa K, Takeda S, Tashiro Y, Yorozu K, Hirata M, Kanada H, Moriguchi Y, Endo K.
    Am J Nephrol; 2012 Sep; 36(5):419-26. PubMed ID: 23128049
    [Abstract] [Full Text] [Related]

  • 7. Impact of cyclosporin on podocyte ZO-1 expression in puromycin aminonucleoside nephrosis rats.
    Kim BS, Park HC, Kang SW, Choi KH, Ha SK, Han DS, Lee HY.
    Yonsei Med J; 2005 Feb 28; 46(1):141-8. PubMed ID: 15744817
    [Abstract] [Full Text] [Related]

  • 8. Adrenomedullin ameliorates podocyte injury induced by puromycin aminonucleoside in vitro and in vivo through modulation of Rho GTPases.
    Dong N, Meng L, Xue R, Yu M, Zhao Z, Liu X.
    Int Urol Nephrol; 2017 Aug 28; 49(8):1489-1506. PubMed ID: 28528353
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Renoprotective effect of the L/N-type calcium channel antagonist cilnidipine on puromycin aminonucleoside-induced nephrosis in rats.
    Takashima K, Nishiyama C, Arisaka N, Takahashi T, Souma S, Tsuda M, Hayashi M, Kasahara H, Kodama H, Tamura T, Murakami M, Kuroda J, Sato F.
    Arzneimittelforschung; 2009 Aug 28; 59(2):79-85. PubMed ID: 19338138
    [Abstract] [Full Text] [Related]

  • 11. Induction of antioxidant enzymes in murine podocytes precedes injury by puromycin aminonucleoside.
    Vega-Warner V, Ransom RF, Vincent AM, Brosius FC, Smoyer WE.
    Kidney Int; 2004 Nov 28; 66(5):1881-9. PubMed ID: 15496159
    [Abstract] [Full Text] [Related]

  • 12. Dynamics of absolute amount of nephrin in a single podocyte in puromycin aminonucleoside nephrosis rats calculated by quantitative glomerular proteomics approach with selected reaction monitoring mode.
    Kawakami H, Kamiie J, Yasuno K, Kobayashi R, Aihara N, Shirota K.
    Nephrol Dial Transplant; 2012 Apr 28; 27(4):1324-30. PubMed ID: 21862459
    [Abstract] [Full Text] [Related]

  • 13. A scanning and transmission electron microscopic comparison of puromycin aminonucleoside-induced nephrosis to hyperalbuminemia-induced proteinuria with emphasis on kidney podocyte pedicel loss.
    Andrews PM.
    Lab Invest; 1977 Feb 28; 36(2):183-97. PubMed ID: 839733
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Fluvastatin ameliorates podocyte injury in proteinuric rats via modulation of excessive Rho signaling.
    Shibata S, Nagase M, Fujita T.
    J Am Soc Nephrol; 2006 Mar 28; 17(3):754-64. PubMed ID: 16452496
    [Abstract] [Full Text] [Related]

  • 16. A novel nuclear factor κB inhibitor, dehydroxymethylepoxyquinomicin, ameliorates puromycin aminonucleoside-induced nephrosis in mice.
    Shimo T, Adachi Y, Yamanouchi S, Tsuji S, Kimata T, Umezawa K, Okigaki M, Takaya J, Ikehara S, Kaneko K.
    Am J Nephrol; 2013 Mar 28; 37(4):302-9. PubMed ID: 23548793
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Antioxidants protect podocyte foot processes in puromycin aminonucleoside-treated rats.
    Ricardo SD, Bertram JF, Ryan GB.
    J Am Soc Nephrol; 1994 Jun 28; 4(12):1974-86. PubMed ID: 7919151
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Effects of celecoxib and nordihydroguaiaretic acid on puromycin aminonucleoside-induced nephrosis in the rat.
    Lee DW, Kwak IS, Lee SB, Song SH, Seong EY, Chung HC, Yang BY, Lee MY, Sol MY.
    J Korean Med Sci; 2009 Jan 28; 24 Suppl(Suppl 1):S183-8. PubMed ID: 19194550
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.